How Does the Recently Discovered Peptide MIP Exhibit Much Higher Binding Affinity Than an Anticancer Protein P53 for an Oncoprotein MDM2?

doi 10.1021/acs.jcim.9b00226.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Stabilization of the MDM2 Oncoprotein by Mutant P53

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Absolute Binding Affinity Calculation for MDM2 Bound to a Disordered Fragment of P53

Biophysical Journal
Biophysics
2013English

Predicting Protein-Peptide Binding Affinity by Learning Peptide-Peptide Distance Functions

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
2005English

Protein-Peptide Molecular Docking With Large-Scale Conformational Changes: The P53-Mdm2 Interaction

Scientific Reports
Multidisciplinary
2016English

Deciphering the Interactions Between an Anticancer Bacteriocin and the P53 DNA Binding Domain

Biophysical Journal
Biophysics
2018English

How Much Binding Affinity Can Be Gained by Filling a Cavity?

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2010English

A Genetic Approach to Mapping the P53 Binding Site in the MDM2 Protein

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
1997English

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

High Affinity Binding of an Engineered, Modular Peptide to Bone Tissue

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy